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Abstract Superoxide generated using exogenous xanthine ox-
idase indirectly activates an uncoupling protein (UCP)-mediated
proton conductance of the mitochondrial inner membrane. We
investigated whether endogenous mitochondrial superoxide pro-
duction could also activate proton conductance. When respiring
on succinate, rat skeletal muscle mitochondria produced large
amounts of matrix superoxide. Addition of GDP to inhibit
UCP3 markedly inhibited proton conductance and increased
superoxide production. Both superoxide production and the
GDP-sensitive proton conductance were suppressed by rotenone
plus an antioxidant. Thus, endogenous superoxide can activate
the proton conductance of UCP3, which in turn limits mitochon-
drial superoxide production. These observations provide a de-
parture point for studies under more physiological conditions.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Uncoupling protein 1 (UCP1) is found exclusively in brown
adipose tissue and mediates adaptive thermogenesis in mam-
mals [1,2]. UCP1 homologues, UCP2 and UCP3, are present
in several mammalian tissues, with UCP3 characteristic of
skeletal muscle mitochondria. Whether the homologues can
also catalyse proton conductance under physiological condi-
tions is debated, but it is clear that neither UCP2 nor UCP3
contributes to the basal proton leak that is a feature of all
mitochondria [3,4].
UCP1, UCP2 and UCP3 all catalyse a superoxide-inducible
proton conductance [5]. Exogenous superoxide generated in
the surrounding medium using xanthine and xanthine oxidase
leads to increased proton transport in a reaction that is po-
tently inhibited by nucleoside di- and triphosphates, including
GDP. The absence of this reaction in mitochondria from
UCP3 knockout mice [4] shows that it is mediated by UCP3
in muscle. Arti¢cially generated superoxide activates UCPs
from the matrix side of the inner membrane, since activation
is prevented by the mitochondrially targeted antioxidant
mitoQ but occurs when mitoQ acts as a superoxide generator
in the matrix [6,7]. The proton conductance of the UCPs can
also be activated by reactive aldehydes such as 4-hydroxy-2-
nonenal [8] and by a carbon-centred radical generator, 2,2P-
azobis(2-methylpropionamidine) dihydrochloride (AAPH) [9].
A mitochondrially targeted carbon-centred radical quencher,
mitoPBN ([4-[4-[[(1,1-dimethylethyl)oxidoimino]methyl]phen-
oxy]-butyl]triphenylphosphonium), prevents activation by
superoxide and AAPH, but not by hydroxynonenal, indicat-
ing that exogenous superoxide activates UCPs through a
pathway of carbon-centred radical production, lipid peroxida-
tion and reactive aldehyde production [9].
An important function of this superoxide-activated path-
way may be to cause mild uncoupling in response to any
overproduction of superoxide by the mitochondrial electron
transport chain, leading to a small decrease in mitochondrial
membrane potential and a consequent strong reduction in
endogenous superoxide production [6,7]. However, activation
of UCPs by superoxide generated endogenously in the mito-
chondrial matrix by the electron transport chain has yet to be
demonstrated experimentally. Indications that it may occur
come from observations that incubation of UCP2-containing
mitochondria with GDP induces an increase in hydrogen per-
oxide generation [10]. Also, superoxide production and
markers of oxidative damage are higher in mitochondria
from UCP2- and UCP3-knockout mice [11^13] and the pro-
ton conductance of mitochondria in intact thymocytes is high-
er when UCP2 is present and active [14].
Most of the superoxide produced in cells is generated by the
mitochondrial electron transport chain. The relative impor-
tance of complex I and complex III is debated [15^18], but
it is matrix superoxide production that will activate UCPs,
and most of this is from complex I [19,20]. Superoxide pro-
duction from this source is maximal when complex II sub-
strates are oxidised in the absence of complex I inhibitors,
so that reverse electron £ow occurs [15^18]. Reverse electron
transport and complex I superoxide production are highly
dependent on mitochondrial proton motive force, which
drives the electrons from complex II thermodynamically up-
hill back into complex I [6,20^22].
This study investigates whether superoxide from endoge-
nous sources in muscle mitochondria can activate mild uncou-
pling that is mediated by UCP3 (and hence sensitive to GDP).
If our model is correct, this activation would serve to atten-
uate mitochondrial superoxide production, so a second aim
was to measure whether inhibition of UCP3 by GDP can
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cause an increase in the rate of endogenous superoxide pro-
duction.
2. Materials and methods
2.1. Isolation of skeletal muscle mitochondria
Skeletal muscle mitochondria were isolated at 4‡C as in [23]. Fe-
male Wistar rats (6^8 weeks old) were stunned and killed by cervical
dislocation. Skeletal muscle from the hindlimbs was dissected and
placed in ice cold CP-1 medium containing 100 mM KCl; 50 mM
Tris^HCl and 2 mM EGTA, pH 7.4, at 4‡C. Muscle tissue was
shredded with a razor blade, minced with scissors, rinsed with CP-1
medium, stirred for 4 min in CP-2 medium (CP-1 plus 1 mM ATP,
5 mM MgCl2, 0.5% (w/v) bovine serum albumin (BSA), 2.1 U ml31
protease (subtilsin), pH 7.4, at 4‡C) and homogenised in CP-2 me-
dium using a polytron tissue homogeniser. The homogenate was
stirred in CP-2 for 6 min, then mitochondria were isolated using
di¡erential centrifugation and resuspended in CP-1 medium. Protein
concentration was determined using the biuret method [24].
2.2. Measurement of mitochondrial hydrogen peroxide production
In the presence of exogenous and matrix superoxide dismutase
(SOD), mitochondrial superoxide production can be measured as
the appearance of hydrogen peroxide in the medium. Hydrogen per-
oxide generation rates were determined £uorometrically by measure-
ment of oxidation of p-hydroxyphenyl acetic acid (PHPA) coupled to
the enzymatic reduction of H2O2 by horseradish peroxidase. The in-
crease in £uorescence at 400 nm with excitation at 320 nm was fol-
lowed on a computer-controlled spectro£uorimeter with appropriate
correction for background and standard curve as in [19]. Mitochon-
dria were incubated at 0.35 mg mitochondrial protein ml31 in assay
bu¡er containing 120 mM KCl, 3 mM HEPES, 1 mM EGTA, 0.3%
(w/v) BSA, 4 mM succinate, 1 mg ml31 oligomycin, 80 ng ml31 niger-
icin, 50 mg ml31 PHPA, 4 U ml31 horseradish peroxidase, 2 WM
triphenylmethyl phosphonium cation (TPMPþ) and 30 U ml31 SOD
(pH 7.2 and 37‡C). When used, 2 WM rotenone, 500 WM GDP and
2 WM mitoVitamin E were added.
2.3. Measurement of proton conductance
The respiration rate of mitochondria, in the presence of oligomycin
to inhibit ATP synthesis, is proportional to the rate at which protons
leak across the inner membrane. The kinetic response of the proton
conductance to its driving force (proton motive force) can therefore be
measured as the relationship between respiration rate and membrane
potential when the potential is varied by titration with electron trans-
port chain inhibitors [23,25,26]. Respiration rate and membrane po-
tential were determined simultaneously using electrodes sensitive to
oxygen and to the potential-dependent probe TPMPþ [27].
Mitochondria (0.35 mg protein ml31) were incubated at 37‡C in
3.5 ml of assay medium identical to the medium for H2O2 detection.
The TPMPþ electrode was calibrated with sequential additions of up
to 2 WM TPMPþ. Four mM succinate was added to start the reaction.
Where indicated, TPMPþ was replaced with identical concentrations
of mitoVitamin E to measure the mitochondrial membrane potential
in the presence of this mitochondrially targeted antioxidant. Respira-
tion and potential were inhibited progressively through successive
steady states by additions of malonate up to 3 mM. To avoid gen-
erating the maximum membrane potential and to limit superoxide
production, where indicated in Fig. 2d, the ¢rst two aliquots of mal-
onate (total 0.35 mM) were added before succinate. At the end of
each run 0.4 WM carbonylcyanide p-tri£uoromethoxy phenylhydra-
zone (FCCP) was added to dissipate the membrane potential and
release all TPMPþ, or mitoVitamin E, back into the media, allowing
correction for any small electrode drift. The TPMPþ(and mitoVitamin
E) binding correction factor was taken as 0.35 Wl mg31 of protein.
This is probably an underestimate for mitoVitamin E, resulting in
overestimation of the membrane potential in Fig. 2c, however, com-
parisons made between conditions both using mitoVitamin E to mea-
sure membrane potential will be valid. Oxygen consumption was mea-
Fig. 1. H2O2 production by muscle mitochondria. For details see Section 2. Rat skeletal muscle mitochondria (0.35 mg protein ml31) were in-
cubated in assay bu¡er (120 mM KCl, 3 mM HEPES, 1 mM EGTA, 0.3% (w/v) BSA, 4 mM succinate, 1 mg ml31 oligomycin, 80 ng ml31 ni-
gericin, 50 mg ml31 PHPA, 4 U ml31 horseradish peroxidase, 2 WM TPMPþ and 30 U ml31 SOD, pH 7.2 and 37‡C). 2 WM rotenone, 500 WM
GDP and 2 WM mitoVitamin E (mVE) were added where indicated. Hydrogen peroxide generation rates were determined £uorometrically.
Data are meansOS.E.M. of three to six independent experiments, each performed in duplicate. *P6 0.05, compared to the same condition in
the absence of GDP by unpaired Student’s t-test.
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sured in the same vessel using a Clark-type oxygen electrode cali-
brated with air-saturated assay medium, which was assumed to con-
tain 406 nmol O ml31 at 37‡C [28]. Electrode linearity from 100^0%
air saturation was checked routinely by following uncoupled respira-
tion with 0.4 WM FCCP.
3. Results and discussion
We ¢rst determined whether isolated skeletal muscle mito-
chondria produced superoxide at signi¢cant rates when respir-
ing in the absence of respiratory inhibitors. Reverse electron
£ow into complex I of the respiratory chain of rat brain, heart
and liver mitochondria, and of submitochondrial particles
from rat brain and bovine heart, can produce large amounts
of superoxide and hydrogen peroxide [15^18]. The same was
true for mitochondria isolated from rat skeletal muscle (Fig.
1). With the complex II substrate succinate, large rates of
hydrogen peroxide production (about 0.5 nmol min31 mg31
protein) were detected, indicating large rates of superoxide
production. Addition of 2 WM rotenone to inhibit complex I
reduced the rate of hydrogen peroxide production by approx-
imately 75%, demonstrating that most of the superoxide was
produced at complex I as a result of reverse electron £ow
from succinate dehydrogenase into complex I. This superoxide
production from complex I is on the matrix side of the inner
membrane [15^18,20].
Since UCPs are stimulated by superoxide produced exoge-
nously using xanthine plus xanthine oxidase, we investigated
whether the endogenous superoxide produced from reverse
electron transport into complex I was su⁄cient to activate
the proton conductance of UCP3. Fig. 2a demonstrates that
under identical conditions to those used to measure superox-
ide production in Fig. 1 there was indeed enough superoxide
produced to activate a UCP3-mediated mild uncoupling of the
mitochondria. There was signi¢cant GDP-sensitive proton
conductance under these conditions: oxygen consumption
driving the proton leak was greater at any given membrane
potential than it was when UCP3 was inhibited by GDP.
Consequently, when UCP3 was activated by endogenous
superoxide, the membrane potential in state 4 was 10 mV
lower than when GDP was present and UCP3 was inhibited
(Fig. 2a).
Fig. 1 shows that addition of rotenone strongly (but not
completely) depressed superoxide production. Fig. 2b shows
that in the presence of rotenone the GDP-sensitive proton
conductance was attenuated, but it was not abolished, partic-
ularly at higher potentials. Even the lowered rate of super-
oxide production in the mitochondrial matrix in the presence
of rotenone appeared to be su⁄cient to activate UCP3 at high
potential.
To further decrease the concentrations of matrix superoxide
and other activatory species, we used the mitochondrially tar-
geted antioxidant, mitoVitamin E. This compound abolishes
activation of UCP2 by exogenously generated superoxide
[6,7]. Fig. 1 shows that when rotenone and mitoVitamin E
C
Fig. 2. E¡ect of superoxide produced endogenously from complex I
on the proton conductance of rat skeletal muscle mitochondria. Rat
skeletal muscle mitochondria (0.35 mg protein ml31) were incubated
at 37‡C in assay bu¡er exactly as in Fig. 1. The kinetics of the mi-
tochondrial proton leak were obtained by simultaneous measure-
ment of membrane potential and oxygen consumption, using succi-
nate as a substrate and varying the potential with sequential
additions of malonate up to 3 mM. a: Sensitivity to 500 WM GDP;
O control; R plus 500 WM GDP. b: Reduction of GDP-sensitivity
in the presence of 2 WM rotenone; E control; F plus 500 WM GDP.
c: Loss of GDP-sensitivity in the presence of 2 WM rotenone and
2 WM mitoVitamin E; a control; b plus 500 WM GDP. d: E¡ect of
initial high potential on subsequent GDP-sensitivity at lower poten-
tial ; O control; R plus 500 WM GDP; 7 control with the ¢rst
two malonate aliquots (0.35 mM) added before succinate; 8 plus
500 WM GDP with 0.35 mM malonate added before succinate. Data
are meansOS.E.M. (or range) of seven (a), three (b,c) or two (d) in-
dependent experiments, each performed in duplicate. The state 4
(i.e. highest) membrane potential was signi¢cantly increased by
GDP in a and b but not in c; P6 0.05 by paired Student’s t-test.
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were both present, superoxide production by muscle mito-
chondria was minimal. Fig. 2c shows that this small rate of
endogenous superoxide production was insu⁄cient to activate
UCP3, as the GDP-sensitive component of the proton con-
ductance seen in Fig. 2a,b was almost totally abolished. The
curves in Fig. 2c are shifted to the right compared to Fig.
2a,b, because of an underestimate of the mitoVitamin E bind-
ing correction factor which results in an overestimation of the
membrane potential, but does not a¡ect comparisons between
curves within Fig. 2c. Previous investigations of endogenous
activation of UCP3 were carried out with rotenone present to
prevent complications due to build-up of oxaloacetate and
inhibition of succinate dehydrogenase, which may explain
why no nucleotide-sensitive basal proton conductance was
observed [5].
Superoxide production by reverse electron transport from
complex I is very sensitive to mitochondrial membrane poten-
tial [6,20^22], yet the endogenous activation of UCP3 per-
sisted even after titration of the potential to low values, where
superoxide production will have ceased (Fig. 2a). Superoxide
activates UCPs indirectly, through lipid peroxidation products
[8], so the activation at low potential in Fig. 2a is probably
caused by the continued presence of these downstream acti-
vators after superoxide production has been abolished by the
decrease in membrane potential. The lack of such activation
in Fig. 2b at low membrane potentials would re£ect decreased
accumulation of downstream activators after smaller initial
superoxide production (Fig. 1). To test whether superoxide
production at high membrane potential (170^180 mV) during
the ¢rst few points of the titration in Fig. 2a led to production
of other more persistent activators, we repeated the experi-
ment but added the ¢rst two aliquots of malonate (0.35
mM) before adding the substrate, so that very high potentials
were never reached, and superoxide and its downstream prod-
ucts could not be formed (Fig. 2d). Under these conditions,
endogenous GDP-sensitive activation was greatly attenuated
at the highest potential reached (165 mV), and abolished at
lower potentials, supporting the suggestion that the persistent
activation at lower potentials in Fig. 2a was indeed caused by
longer-lived downstream activators formed only when large
amounts of superoxide were generated at the highest poten-
tials.
Proton transport by UCP1 requires free fatty acids [2], so
the UCP1 homologues might also require free fatty acids if
they perform a similar function. This is the case when the
proton conductances of UCP2 and UCP3 are activated by
exogenous superoxide from xanthine oxidase [5]. However,
when superoxide was produced in the matrix of UCP2-con-
taining mitochondria by using mitoQ [7], or when UCPs were
directly activated using hydroxynonenal [8], a GDP-sensitive
proton conductance was observed even in the presence of
BSA, a fatty acid chelator. All the experiments in this study
were performed in the presence of BSA, with no added fatty
acid, yet we observed GDP-sensitive proton conductance.
Therefore, when superoxide from the matrix activates the pro-
ton conductance of UCP2 or UCP3, added fatty acids are not
required, suggesting that fatty acids may only be required for
the entry of superoxide into the matrix when it is generated
externally.
These ¢ndings show that the proton conductance of UCP3
in skeletal muscle mitochondria can be activated indirectly by
superoxide generated endogenously by the mitochondrial elec-
tron transport chain. The activation diminished as superoxide
production was attenuated, but even quite low rates of endog-
enous superoxide production were su⁄cient to activate UCP3
and cause a mild uncoupling of the mitochondria. The pres-
ence and signi¢cance of this activation in intact cells have yet
to be demonstrated.
We have proposed that activation of mild uncoupling by
UCPs is a mechanism to decrease endogenous superoxide
production. In the second part of this study we investigated
whether inhibition of UCP3 prevented this feedback and re-
leased the control it is postulated to exert over superoxide
production. Fig. 1 shows that inhibition of UCP3 by GDP
did indeed allow higher rates of superoxide production from
the electron transport chain: in the absence of rotenone, ad-
dition of 500 WM GDP, to fully inhibit UCP3, augmented
superoxide production by about 75%. This enhanced super-
oxide production can be explained by the 10 mV increase in
membrane potential seen in Fig. 2a when UCP3 was inhibited
by GDP, due to the steep dependence of superoxide produc-
tion on membrane potential [20^22]. Even when complex I
was inhibited using rotenone, addition of GDP to abolish
superoxide activation of UCP3 still resulted in signi¢cant in-
creases in membrane potential (Fig. 2b) and in the rate of
superoxide production (Fig. 1).
These data show that the mitochondrial electron transport
chain can produce su⁄cient superoxide to activate the proton
conductance of UCP3. Activation of UCP3 causes mild un-
coupling, which lowers vp and decreases reverse electron
transport into complex I, resulting in decreased superoxide
production from complex I and other sites in the respiratory
chain. UCPs can thus act as part of a feedback mechanism to
limit the rate of endogenous superoxide production in the
mitochondrial matrix, and so act to limit oxidative damage.
These observations provide a departure point for studies
under more complex conditions, including the presence of
physiological concentrations of purine nucleotides.
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